• Loading stock data…

Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie

Last Updated on September 13, 2023 by


Print Friendly, PDF & Email
Spread the word

Reader Interactions

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Generated by Feedzy
%d bloggers like this: